🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase one study to assess the safety of daily dosing of Lactobaci...
Status
Completed
Location
Community of Santa Clara
Start Date
2010-02
Trial ID
NCT00774163
Treatments Being Tested
The purpose of this study is to compare the safety and preliminary efficacy...
Status
Completed
Location
Chiba University Hospital
Start Date
2019-05-23
Trial ID
NCT03955315
The first testing of TargomiRs in the human setting: dose-finding studies i...
Status
Completed
Location
Concord Repatriation General Hospital
Start Date
2014-09
Trial ID
NCT02369198
Treatments Being Tested
Dyspepsia refers to chronic or recurrent upper gastrointestinal (GI) sympto...
Status
Recruiting
Location
KU Leuven
Start Date
2024-10-01
Trial ID
NCT06482671
Treatments Being Tested
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
The purpose of this study is to evaluate safety, tolerability, immunogenici...
Status
Completed
Location
CMAX Clinical Research
Start Date
2020-12-30
Trial ID
NCT05490017
The purpose of this study is to confirm the clinical efficacy and the safet...
Status
Completed
Location
Site #102
Start Date
2016-08-02
Trial ID
NCT03004469
Treatments Being Tested
The purpose of this research study is to test if an experimental drug calle...
Status
Withdrawn
Location
J. Edward Puzas
Start Date
2008-12
Trial ID
NCT00787358
The purpose of this study is to evaluate the clinical efficacy and safety o...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT02235272
This study assessed pasireotide LAR efficacy on patients with non-functioni...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-11-26
Trial ID
NCT01283542
Treatments Being Tested